Bioanalytical Systems (BASI) Reports Q4 Loss of $0.09/Share

Bioanalytical Systems (NASDAQ: BASI) reported Q4 EPS of ($0.09), versus ($0.05) reported last year. Revenue for the quarter came in at $4.98 million, versus $6.42 million reported last year.

For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c